novavax inc (NVAX:NASDAQ GS)
Earnings & Estimates Summary - NOVAVAX INC (NVAX)
2013 revenues at Novavax, Inc. totaled $20.9M USD, while annual losses equaled $0.31 per share.
Quarterly Earnings & Estimates - NOVAVAX INC (NVAX)
Novavax, Inc.'s Quarterly Earnings
Novavax, Inc. reported 1st quarter 2014 losses of $0.07 per share on 05/9/2014.
Annual Earnings & Estimates - NOVAVAX INC (NVAX)
Novavax, Inc.'s Annual Earnings
Novavax, Inc. reported annual 2013 losses of $0.31 per share on 03/12/2014.
Quarterly Revenues - NOVAVAX INC (NVAX)
Novavax, Inc.'s Quarterly Revenues
Novavax, Inc. had 1st quarter 2014 revenues of $7.5M USD. This bettered the $6.8M USD consensus of the 2 analysts covering the company. This was 94.7% above the prior year's 1st quarter results.
Annual Revenues - NOVAVAX INC (NVAX)
Novavax, Inc.'s Annual Revenues
Novavax, Inc. had revenues for the full year 2013 of $20.9M USD. This was -5.3% below the prior year's results.
|Celldex Therapeutics Inc||$16.15 USD||-0.27|
|Dynavax Technologies Corp||$1.42 USD||-0.03|
|Inovio Pharmaceuticals Inc||$10.75 USD||+0.43|
|Progenics Pharmaceuticals Inc||$5.43 USD||-0.01|
|Transgene SA||€8.44 EUR||+0.01|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|